Upload

Loading...

Clinical Trials - from Company through FDA to Patient

5,456

Loading...

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 22, 2012

Learn about clinical trials - the steps involved in the testing of a new medicine - and what is required by the FDA to gain approval so these innovative new medicines can reach those who need them the most.

The biopharmaceutical industry in the United States is responsible for the research, manufacturing and delivery of safe and effective new medicines to patients.

Learn more about clinical trials, including state reports, at http://www.phrma.org/research/clinica...

Loading...

  1. 73

    Panel 3 - Progress Module: Innovation & Disruption and What Can We Learn?

  2. 74

    Dr. Joe Miletich of Amgen explains biologics, why the future is promising

  3. 75

    PhRMA 2012 Year in Review

  4. 76

    PDUFA V

  5. 77

    New Medicines in the U.S. Biopharmaceutical Pipeline Webinar Jan. 17, 2013, Part III

  6. 78

    New Medicines in the U.S. Biopharmaceutical Pipeline Webinar Jan. 17, 2013, Part II

  7. 79

    New Medicines in the U.S. Biopharmaceutical Pipeline Webinar Jan. 17, 2013, Part I

  8. 80

    Innovations and Inaugurations

  9. 81

    Dr. Bob Ratner of the American Diabetes Association Talks about Prevalence of Diabetes

  10. 82

    Jeffrey Brewer, President & CEO of JDRF, Talks about Type 1 Diabetes, Focus on Curing the Disease

  11. 83

    Matthias von Herrath of Novo Nordisk discusses the diabetes epidemic and the hope for the future

  12. 84

    Step Out: Walk to Stop Diabetes®

  13. 85

    Elizabeth Zabell Edelman of Diabetes Daily talks to PhRMA

  14. 86

    Stevin Zorn of Lundbeck talks advances in mental health and addictive disorders

  15. 87

    From Hope to Cures - John Castellani

  16. 88

    Neha Chauhan is the 2012 Research and Hope Volunteer Champion Awardee

  17. 89

    Research and Hope Awardees in their own words on why they want to see a cure for Alzheimer's disease

  18. 90

    Research and Hope Awards co-sponsors discuss their roles in the search for a cure for Alzheimer's

  19. 91

    Research and Hope Award Winner Katie Maslow Discusses her Work on Alzheimer's

  20. 92

    Generic Drugs: Learn about the Lifecycle from Brand Name Prescriptions to Generics

  21. 93

    Clinical Trials

  22. 94

    Scope It Out 5K for Colon Cancer

  23. 95

    Special Olympics DC & PhRMA

  24. 96

    Cancer Survivor Susan Parkinson talks about her battle with Non-Hodgkin's Lymphoma

  25. 97

    Medicines in Development for Cancer: A Timeline

  26. 98

    The Best Preparation for the Worst Asthma Attack

  27. 99

    Doing More in Challenging Times - A Conversation at PhRMA12 in Boston

  28. 100

    The Innovation Ecosystem - A Conversation at PhRMA12 in Boston

  29. 101

    President's Address - John Castellani Address at PhRMA12 in Boston

  30. 102

    Rare No More - A Conversation at PhRMA12 in Boston

  31. 103

    More for the Patient - A discussion on improving health at PhRMA12 in Boston

  32. 104

    Massachusetts Governor Welcome Address at PhRMA12 in Boston

  33. 105

    Chairman Christopher Viehbacher's Welcome and Address at PhRMA12 in Boston

  34. 106

    Incoming PhRMA Chairman Remarks - John C. Lechleiter, PhD at PhRMA12 in Boston

  35. 107

    A Global Opportunity: Emerging Markets Conversation at PhRMA12 in Boston

  36. 108

    Robert Coughlin Address at PhRMA12 in Boston

  37. 109

    Conversation with PhRMA Leadership: Christopher Viehbacher and John Lechleiter at PhRMA12 in Boston

  38. 110

    Prescription Drug Shortages Dos and Donts from PhRMA

  39. 111

    NAPWA President and CEO Frank Oldham, Jr. on alliances with the pharmaceutical industry

  40. 112

    NCOA President & CEO discusses the importance of partnerships, PhRMA Annual Meeting

  41. 113

    Dr. Timothy Cote of NORD talks about PhRMA's Upcoming Annual Meeting, New Therapies

  42. 114

    Medicines in Development for Asthma, helping to make breathing easier

  43. 115

    PhRMA President & CEO John J. Castellani Introduces the Drug Shortages Resource Center

  44. 116

    Learn About New HIV AIDs Medicines in Development: Getting to Zero

  45. 117

    The Catalyst Interviews Medicare Today on Enrollment, Satisfaction and Changes to Coverage Plans

  46. 118

    It Started with Pancakes: Alzheimer's Through the Eyes of a Researcher & Caregiver

  47. 119

    A Caregiver's Story: Alzheimer's is a Cruel Disease

  48. 120

    DC Walk Raises Awareness of Parkinson's Disease; PhRMA - 36 Medicines in Development (Long)

  49. 121

    DC Walk Raises Awareness of Parkinson's Disease; PhRMA - 36 Medicines in Development (short)

  50. 122

    Learn about the 2011 Medicare Open Enrollment Period: Get a Plan that Meets Your Needs

  51. 123

    Biotechnology: Learn about New Biological Medicines in Development

  52. 124

    Medicare Part D - the Prescription Drug Plan - is Working for Seniors

  53. 125

    Juvenile Rheumatoid Arthritis (JRA) Affects 300,000 Kids; Learn About Therapies and Treatments

  54. 126

    Dr. Payne on Reviving the Pipeline of Life-Saving Antibiotics

  55. 127

    Dr. Eisenstein on Reviving the Pipeline of Life-Saving Antibiotics

  56. 128

    PhRMA Chairman Chris Viehbacher on Biopharmaceutical Industry Mission, Access to Care, Part D

  57. 129

    Learn About Medicine Adherence: Why Following a Physician's Instructions is Important

  58. 130

    Recipe for Hope

  59. 131

    Learn About New Medicines in Development to Treat Arthritis

  60. 132

    Arthritis

  61. 133

    Emerging Companies

  62. 134

    Matt Boyd highlights some takeaways from the PhRMA11 Social Media Summit

  63. 135

    Erin Beals Discusses the PhRMA11 Social Media Summit

  64. 136

    Christian Clymer discusses lessons learned from the PhRMA11 Social Media Summit

  65. 137

    Ben Atkins speaks on lessons learned from the PhRMA11 Social Media Summit

  66. 138

    Greg Kueterman of Eli Lilly covers some highlights from the PhRMA11 Social Media Summit

  67. 139

    Mike Capaldi provides a recap of the Social Media Summit PhRMA11 #4 of 4

  68. 140

    Mike Capaldi provides a recap of the Social Media Summit PhRMA11 #3 of 4

  69. 141

    Mike Capaldi provides a recap of the Social Media Summit PhRMA11 #2 of 4

  70. 142

    Mike Capaldi provides a recap of the Social Media Summit PhRMA11 #1 of 4

  71. 143

    Sean Donahue recaps his talk at the Social Media Summit PhRMA11 #4 of 4

  72. 144

    Sean Donahue recaps his talk at the Social Media Summit PhRMA11 #3 of 4

  73. 145

    Sean Donahue recaps his talk at the Social Media Summit PhRMA11 #2 of 4

  74. 146

    Sean Donahue recaps his talk at the Social Media Summit PhRMA11 #1 of 4

  75. 147

    Amy O'Connor recaps her presentation at the Social Media Summit PhRMA11 #5 of 5

  76. 148

    Amy O'Connor recaps her presentation at the Social Media Summit PhRMA11 #4 of 5

  77. 149

    Amy O'Connor recaps her presentation at the Social Media Summit PhRMA11 #3 of 5

  78. 150

    Amy O'Connor recaps her presentation at the Social Media Summit PhRMA11 #2 of 5

  79. 151

    Amy O'Connor recaps her presentation at the Social Media Summit PhRMA11 #1 of 5

  80. 152

    Ray Kerins recaps his talk at the Social Media Summit PhRMA11 #4 of 4

  81. 153

    Ray Kerins recaps his talk at the Social Media Summit PhRMA11 #3 of 4

  82. 154

    Ray Kerins recaps his talk at the Social Media Summit PhRMA11 #2 of 4

  83. 155

    Ray Kerins recaps his talk at the Social Media Summit PhRMA11 #1 of 4

  84. 156

    Sarah Kliff Recaps Conversation at Social Media Summit PhRMA11 #5 of 5

  85. 157

    Sarah Kliff Recaps Conversation at Social Media Summit PhRMA11 #4 of 5

  86. 158

    Sarah Kliff Recaps Conversation at Social Media Summit PhRMA11 #3 of 5

  87. 159

    Sarah Kliff Recaps Conversation at Social Media Summit PhRMA11 #2 of 5

  88. 160

    Sarah Kliff Recaps Conversation at Social Media Summit PhRMA11 #1 of 5

  89. 161

    Sharecare's Jeff Arnold Spoke at PhRMA11

  90. 162

    Fighting HIV:AIDS

  91. 163

    PPA Thanks

  92. 164

    PhRMA11: Governors Panel

  93. 165

    Multiple Sclerosis and Women

  94. 166

    New Medicines in Development for Women

  95. 167

    PhRMA11 Day 1 Session 9: Addressing Disease and Deficits

  96. 168

    PhRMA11 Day 1 Session 6: Tribute

  97. 169

    Company Profile: Daiichi Sankyo, Inc.

  98. 170

    PhRMA11 Day 1 Session 5: Coach K

  99. 171

    PhRMA11 Day 1 Session 8: The Future of Health and Investing in Innovation

Sign in to add this to Watch Later

Add to